Skip to main content
Top

04-01-2025 | Toxoplasmosis | Original Article

Toxoplasma gondii seroprevalence and associated factors among pregnant women attending their first antennal care visit in rural Burkina Faso

Authors: Marc Christian Tahita, Bérenger Kaboré, Hamidou Ilboudo, Nadege Zoma, Helkana Melika Sougue, Adama Kazienga, Esther Nadia Ouedraogo, Bienvenu Nana, Elodie D. G. Sanon, Regina Sinner, Halidou Tinto, Judith M. Hübschen

Published in: Journal of Parasitic Diseases

Login to get access

Abstract

Toxoplasma gondii, responsible for toxoplasmosis, is one of the worldwide prevalent parasitic zoonoses infecting warm-blooded animals including humans with cats being the definitive host. Congenital transmission can occur and leads to congenital toxoplasmosis, which may result in foetal or neonatal death, or severe malformations. In this study, we aimed to determine the seroprevalence and associated factors among pregnant women in a rural setting of Burkina Faso. We conducted a cross-sectional study from December 2020 to March 2021 in the Nanoro health district area. Women attending antenatal care for the first time at the selected health centers were enrolled in the study. For each participant, socio-demographic and clinical data were collected through a questionnaire. In addition, venous blood was drawn for the detection and avidity determination of IgG antibodies to T. gondii by enzyme-linked immunosorbent assay. Logistic regression was used to identify factors associated with seropositivity. Out of 416 participants, 37.3% were positive for specific anti-T. gondii IgG antibodies and only two of 149 women with interpretable results (1.3%) had low avidity IgG antibodies suggestive of recent primary infection. Younger age (16–18 years) was significantly associated with seronegativity (OR = 0.48, 95% CI:0.27–0.86, p = 0.013), while multipara (OR = 2.20, 95% CI:1.37–3.76, p value = 0.001) and multigravida (OR = 2.27, 95% CI:1.37–3.76, p = 0.001) were significantly more likely seropositive. The multivariate logistic regression showed that being at the third trimester of pregnancy (OR = 4.17, 95% CI:1.68–10.36, p = 0.002) and being often in contact with a cat (OR = 1.72, 95% CI:1.03–2.37, p = 0.035) were significantly associated with seropositivity. Our findings suggest that Toxoplasma gondii is widespread in the area, resulting in a high exposure risk of pregnant women and we indeed found two women with evidence of recent exposure. To avoid the potentially serious consequences to the foetus, there is an urgent need for systematic screening during antenatal care visits and awareness campaigns.
Literature
go back to reference Alsammani MA (2016) Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries. J Parasit Dis 40(3):569–579CrossRefPubMed Alsammani MA (2016) Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries. J Parasit Dis 40(3):569–579CrossRefPubMed
go back to reference Ayi I, Edu SAA, Apea-Kubi KA, Boamah D, Bosompem KM, Edoh D (2009) Sero-epidemiology of toxoplasmosis amongst pregnant women in the greater Accra region of Ghana. Ghana Med J 43(3):107–114PubMedPubMedCentral Ayi I, Edu SAA, Apea-Kubi KA, Boamah D, Bosompem KM, Edoh D (2009) Sero-epidemiology of toxoplasmosis amongst pregnant women in the greater Accra region of Ghana. Ghana Med J 43(3):107–114PubMedPubMedCentral
go back to reference Bamba S, Cisse M, Sangare I, Zida A, Ouattara S, Guiguemde RT (2017) Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women from Bobo Dioulasso, Burkina Faso. BMC Infect Dis 17(1):482CrossRefPubMedPubMedCentral Bamba S, Cisse M, Sangare I, Zida A, Ouattara S, Guiguemde RT (2017) Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women from Bobo Dioulasso, Burkina Faso. BMC Infect Dis 17(1):482CrossRefPubMedPubMedCentral
go back to reference Bamba S, Some DA, Chemla C, Geers R, Guiguemdé RT, Villena I (2012) Analyse sérologique De La toxoplasmose pergravidique evaluation des risques et perspectives du depistage prenatal Au Chu De Bobo Dioulasso. Pan Afr Med J. 12(43) Bamba S, Some DA, Chemla C, Geers R, Guiguemdé RT, Villena I (2012) Analyse sérologique De La toxoplasmose pergravidique evaluation des risques et perspectives du depistage prenatal Au Chu De Bobo Dioulasso. Pan Afr Med J. 12(43)
go back to reference Bigna JJ, Tochie JN, Tounouga DN, Bekolo AO, Ymele NS, Youda EL, Sime PS, Nansseu JR (2020) Global, regional, and country seroprevalence of Toxoplasma gondii in pregnant women: a systematic review, modelling and meta-analysis. Sci Rep 10(1):12102CrossRefPubMedPubMedCentral Bigna JJ, Tochie JN, Tounouga DN, Bekolo AO, Ymele NS, Youda EL, Sime PS, Nansseu JR (2020) Global, regional, and country seroprevalence of Toxoplasma gondii in pregnant women: a systematic review, modelling and meta-analysis. Sci Rep 10(1):12102CrossRefPubMedPubMedCentral
go back to reference Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington J, Withers S, Meier P, McLeod R, the Toxoplasmosis Study Group (2005) Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am J Obstet Gynecol 192(2):564–571 Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington J, Withers S, Meier P, McLeod R, the Toxoplasmosis Study Group (2005) Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am J Obstet Gynecol 192(2):564–571
go back to reference Cook AJC, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, Foulon W, Semprini AE, Dunn DT (2000) Sources of toxoplasma infection in pregnant women: European multicentre casecontrol study. BMJ 321:142–147CrossRefPubMedPubMedCentral Cook AJC, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, Foulon W, Semprini AE, Dunn DT (2000) Sources of toxoplasma infection in pregnant women: European multicentre casecontrol study. BMJ 321:142–147CrossRefPubMedPubMedCentral
go back to reference Deganich M, Boudreaux C, Benmerzouga I (2022) Toxoplasmosis infection during pregnancy. Trop Med Infect Dis 8(1) Deganich M, Boudreaux C, Benmerzouga I (2022) Toxoplasmosis infection during pregnancy. Trop Med Infect Dis 8(1)
go back to reference Doudou Y, Renaud P, Coralie L, Jacqueline F, Hypolite S, Hypolite M, Patrick M, Andreia Ida L, Van Sprundel M, Marleen B et al (2014) Toxoplasmosis among pregnant women: high seroprevalence and risk factors in Kinshasa, Democratic Republic of Congo. Asian Pac J Trop Biomed 4(1):69–74CrossRefPubMed Doudou Y, Renaud P, Coralie L, Jacqueline F, Hypolite S, Hypolite M, Patrick M, Andreia Ida L, Van Sprundel M, Marleen B et al (2014) Toxoplasmosis among pregnant women: high seroprevalence and risk factors in Kinshasa, Democratic Republic of Congo. Asian Pac J Trop Biomed 4(1):69–74CrossRefPubMed
go back to reference Dubey JP (2008) The history of Toxoplasma gondii—the first 100 years. J Eukaryot Microbiol 55(6):467–475CrossRefPubMed Dubey JP (2008) The history of Toxoplasma gondii—the first 100 years. J Eukaryot Microbiol 55(6):467–475CrossRefPubMed
go back to reference Esther Hien Y, Denise Ilboudo P, Donatien K, Dramane G, Rokiatou S, Sawadogo H, Sawadogo M, Kabre S, Savadogo E, Traore A Y (2021) Toxoplasma gondii infection in pregnant women: seroprevalence and associated risk factors in ouagadougou, Burkina Faso. Am J Infect Dis Microbiol 9(3):83–89 Esther Hien Y, Denise Ilboudo P, Donatien K, Dramane G, Rokiatou S, Sawadogo H, Sawadogo M, Kabre S, Savadogo E, Traore A Y (2021) Toxoplasma gondii infection in pregnant women: seroprevalence and associated risk factors in ouagadougou, Burkina Faso. Am J Infect Dis Microbiol 9(3):83–89
go back to reference Fenta DA (2019) Seroprevalence of Toxoplasma gondii among pregnant women attending antenatal clinics at Hawassa University comprehensive specialized and Yirgalem General Hospitals, in southern Ethiopia. BMC Infect Dis 19(1):1056CrossRefPubMedPubMedCentral Fenta DA (2019) Seroprevalence of Toxoplasma gondii among pregnant women attending antenatal clinics at Hawassa University comprehensive specialized and Yirgalem General Hospitals, in southern Ethiopia. BMC Infect Dis 19(1):1056CrossRefPubMedPubMedCentral
go back to reference Fricker-Hidalgo H, Bailly S, Brenier-Pinchart MP, Dard C, Jean D, Coston AL, Garnaud C, Pelloux H (2020) How to estimate time of infection with Toxoplasma gondii in pregnant women. Use of specific igg and igm kinetics by 7 techniques on 691 sera. Diagn Microbiol Infect Dis 96(4):114987CrossRefPubMed Fricker-Hidalgo H, Bailly S, Brenier-Pinchart MP, Dard C, Jean D, Coston AL, Garnaud C, Pelloux H (2020) How to estimate time of infection with Toxoplasma gondii in pregnant women. Use of specific igg and igm kinetics by 7 techniques on 691 sera. Diagn Microbiol Infect Dis 96(4):114987CrossRefPubMed
go back to reference Halonen SK, Weiss LM (2013) Toxoplasmosis. Handb Clin Neurol 114:125–145 Halonen SK, Weiss LM (2013) Toxoplasmosis. Handb Clin Neurol 114:125–145
go back to reference Hassanen EAA, Makau DN, Afifi M, Al-Jabr OA, Abdulrahman Alshahrani M, Saif A, Anter RGA, El-Neshwy WM, Ibrahim D, Abou Elez RMM (2023) Interplay between cross sectional analysis of risk factors associated with Toxoplasma gondii infection in pregnant women and their domestic cats. Front Vet Sci 10:1147614CrossRefPubMedPubMedCentral Hassanen EAA, Makau DN, Afifi M, Al-Jabr OA, Abdulrahman Alshahrani M, Saif A, Anter RGA, El-Neshwy WM, Ibrahim D, Abou Elez RMM (2023) Interplay between cross sectional analysis of risk factors associated with Toxoplasma gondii infection in pregnant women and their domestic cats. Front Vet Sci 10:1147614CrossRefPubMedPubMedCentral
go back to reference Holec-Gasior L, Solowinska K (2022) IgG avidity test as a tool for discrimination between recent and distant Toxoplasma gondii infection-current status of studies. Antibodies 11(3) Holec-Gasior L, Solowinska K (2022) IgG avidity test as a tool for discrimination between recent and distant Toxoplasma gondii infection-current status of studies. Antibodies 11(3)
go back to reference Jenum PA, Stray-Pedersen B, Melby K, Kapperud G, Whitelaw A, Eskild A, Eng J (1998) Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 36(10):2900–2906CrossRefPubMedPubMedCentral Jenum PA, Stray-Pedersen B, Melby K, Kapperud G, Whitelaw A, Eskild A, Eng J (1998) Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 36(10):2900–2906CrossRefPubMedPubMedCentral
go back to reference Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB (2001) Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 150(4):357–365CrossRef Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB (2001) Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 150(4):357–365CrossRef
go back to reference Liesenfeld O, Press C, Montaya JG, Gill R, Judith L, Isaac-Rnton, Hedman K, Remington JS (1997) False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 35:174–178CrossRefPubMedPubMedCentral Liesenfeld O, Press C, Montaya JG, Gill R, Judith L, Isaac-Rnton, Hedman K, Remington JS (1997) False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 35:174–178CrossRefPubMedPubMedCentral
go back to reference Linguissi LS, Nagalo BM, Bisseye C, Kagone TS, Sanou M, Tao I, Benao V, Simpore J, Kone B (2012) Seroprevalence of toxoplasmosis and rubella in pregnant women attending antenatal private clinic at Ouagadougou, Burkina Faso. Asian Pac J Trop Med 5(10):810–813CrossRefPubMed Linguissi LS, Nagalo BM, Bisseye C, Kagone TS, Sanou M, Tao I, Benao V, Simpore J, Kone B (2012) Seroprevalence of toxoplasmosis and rubella in pregnant women attending antenatal private clinic at Ouagadougou, Burkina Faso. Asian Pac J Trop Med 5(10):810–813CrossRefPubMed
go back to reference Mabeku LBK, Tchakounte C, Bonsi ST, Etoa FX (2018) Prevalence of Toxoplasma gondii and associated risk factors among pregnant women attending hospital centers in penka-michel, Cameroon. J Sci Res Rep 21(2):1–11CrossRef Mabeku LBK, Tchakounte C, Bonsi ST, Etoa FX (2018) Prevalence of Toxoplasma gondii and associated risk factors among pregnant women attending hospital centers in penka-michel, Cameroon. J Sci Res Rep 21(2):1–11CrossRef
go back to reference Ministère de la Santé du Burkina Faso SG (2021) Direction Générale Des Etudes et de la Statistique Sectorielle, 2021. Annuaire statistiques 2020. Ministère de la santé du Burkina Faso Ministère de la Santé du Burkina Faso SG (2021) Direction Générale Des Etudes et de la Statistique Sectorielle, 2021. Annuaire statistiques 2020. Ministère de la santé du Burkina Faso
go back to reference Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965–1976 Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965–1976
go back to reference Mwambe B, Mshana SE, Kidenya BR, Massinde AN, Mazigo HD, Michael D, Majinge C, Grob U (2013) Sero-prevalence and factors associated with Toxoplasma gondii infection among pregnant women attending antenatal care in Mwanza, Tanzania. Parasites Vectors 6(222). Mwambe B, Mshana SE, Kidenya BR, Massinde AN, Mazigo HD, Michael D, Majinge C, Grob U (2013) Sero-prevalence and factors associated with Toxoplasma gondii infection among pregnant women attending antenatal care in Mwanza, Tanzania. Parasites Vectors 6(222).
go back to reference Ndiaye M, Seck A, Ndiaye B, Diallo TA, Diop A, Seck MC, Badiane AS, Diallo MA, Kouedvidjin E (2022) Age-associated seroprevalence of Toxoplasma gondii in 10892 pregnant women in senegal between 2016 and 2019. J Bacteriol Parasitol 13(429) Ndiaye M, Seck A, Ndiaye B, Diallo TA, Diop A, Seck MC, Badiane AS, Diallo MA, Kouedvidjin E (2022) Age-associated seroprevalence of Toxoplasma gondii in 10892 pregnant women in senegal between 2016 and 2019. J Bacteriol Parasitol 13(429)
go back to reference Nogareda F, Le Strat Y, Villena I, De Valk H, Goulet V (2014) Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimation. Epidemiol Infect 142(8):1661–1670CrossRefPubMed Nogareda F, Le Strat Y, Villena I, De Valk H, Goulet V (2014) Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimation. Epidemiol Infect 142(8):1661–1670CrossRefPubMed
go back to reference Olarinde O, Sowemimo OA, Chuang TW, Chou CM, Olasanmi SO, Ikotun K, Akinwale OP, Gyang VP, Nwafor T, Olukosi AY et al (2022) Toxoplasma gondii infection: seroprevalence and associated risk factors for women of childbearing age in Osun State, Nigeria. Pathog Glob Health 116(1):59–65CrossRefPubMed Olarinde O, Sowemimo OA, Chuang TW, Chou CM, Olasanmi SO, Ikotun K, Akinwale OP, Gyang VP, Nwafor T, Olukosi AY et al (2022) Toxoplasma gondii infection: seroprevalence and associated risk factors for women of childbearing age in Osun State, Nigeria. Pathog Glob Health 116(1):59–65CrossRefPubMed
go back to reference Oyeyemi OT, Oyeyemi IT, Adesina IA, Tiamiyu AM, Oluwafemi YD, Nwuba RI, Grenfell RFQ (2020) Toxoplasmosis in pregnancy: a neglected bane but a serious threat in Nigeria. Parasitology 147(2):127–134CrossRefPubMed Oyeyemi OT, Oyeyemi IT, Adesina IA, Tiamiyu AM, Oluwafemi YD, Nwuba RI, Grenfell RFQ (2020) Toxoplasmosis in pregnancy: a neglected bane but a serious threat in Nigeria. Parasitology 147(2):127–134CrossRefPubMed
go back to reference Pegha Moukandja I, Ngoungou EB, Lemamy GJ, Bisvigou U, Gessain A, Toure Ndouo FS, Kazanji M, Lekana-Douki JB (2017) Non-malarial infectious diseases of antenatal care in pregnant women in franceville, Gabon. BMC Pregnancy Childbirth 17(1):185CrossRefPubMedPubMedCentral Pegha Moukandja I, Ngoungou EB, Lemamy GJ, Bisvigou U, Gessain A, Toure Ndouo FS, Kazanji M, Lekana-Douki JB (2017) Non-malarial infectious diseases of antenatal care in pregnant women in franceville, Gabon. BMC Pregnancy Childbirth 17(1):185CrossRefPubMedPubMedCentral
go back to reference Petersson K, Stray-Pedersen B, Malm G, Forsgren M, EvengÅRd B (2000) Seroprevalence of Toxoplasma gondii among pregnant women in Sweden. Acta Obstet Gynecol Scand 79(10):824–829CrossRefPubMed Petersson K, Stray-Pedersen B, Malm G, Forsgren M, EvengÅRd B (2000) Seroprevalence of Toxoplasma gondii among pregnant women in Sweden. Acta Obstet Gynecol Scand 79(10):824–829CrossRefPubMed
go back to reference Peyron F, L’Ollivier C, Mandelbrot L, Wallon M, Piarroux R, Kieffer F, Hadjadj E, Paris L, Garcia-Meric P (2019) Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations of a French multidisciplinary working group. Pathogens 8(1) Peyron F, L’Ollivier C, Mandelbrot L, Wallon M, Piarroux R, Kieffer F, Hadjadj E, Paris L, Garcia-Meric P (2019) Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations of a French multidisciplinary working group. Pathogens 8(1)
go back to reference Rostami A, Riahi SM, Gamble HR, Fakhri Y, Nourollahpour Shiadeh M, Danesh M, Behniafar H, Paktinat S, Foroutan M, Mokdad AH et al (2020) Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clin Microbiol Infect 26(6):673–683CrossRefPubMed Rostami A, Riahi SM, Gamble HR, Fakhri Y, Nourollahpour Shiadeh M, Danesh M, Behniafar H, Paktinat S, Foroutan M, Mokdad AH et al (2020) Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clin Microbiol Infect 26(6):673–683CrossRefPubMed
go back to reference Rouatbi M, Amairia S, Amdouni Y, Boussaadoun MA, Ayadi O, Al-Hosary AAT, Rekik M, Ben Abdallah R, Aoun K, Darghouth MA et al (2019) Toxoplasma gondii infection and toxoplasmosis in north africa: a review. Parasite 26:6CrossRefPubMedPubMedCentral Rouatbi M, Amairia S, Amdouni Y, Boussaadoun MA, Ayadi O, Al-Hosary AAT, Rekik M, Ben Abdallah R, Aoun K, Darghouth MA et al (2019) Toxoplasma gondii infection and toxoplasmosis in north africa: a review. Parasite 26:6CrossRefPubMedPubMedCentral
go back to reference Sensini A (2006) Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis. Clin Microbiol Infect 12(6):504–512CrossRefPubMed Sensini A (2006) Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis. Clin Microbiol Infect 12(6):504–512CrossRefPubMed
go back to reference Singh B, Debrah LB, Acheampong G, Debrah AY (2021) Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women in Kumasi: a cross-sectional study at a district-level hospital, Ghana. Infect Dis Obstet Gynecol 2021:6670219 Singh B, Debrah LB, Acheampong G, Debrah AY (2021) Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women in Kumasi: a cross-sectional study at a district-level hospital, Ghana. Infect Dis Obstet Gynecol 2021:6670219
go back to reference Teimouri A, Mohtasebi S, Kazemirad E, Keshavarz H (2020) Role of Toxoplasma gondii IgG avidity testing in discriminating between acute and chronic toxoplasmosis in pregnancy. J Clin Microbiol 58(9) Teimouri A, Mohtasebi S, Kazemirad E, Keshavarz H (2020) Role of Toxoplasma gondii IgG avidity testing in discriminating between acute and chronic toxoplasmosis in pregnancy. J Clin Microbiol 58(9)
go back to reference Tonouhewa ABN, Amagbegnon R, Atchade SP, Hamidovic A, Mercier A, Dambrun M, Migot-Nabias F, Savi de Tove YS, Sahibi H, Laboudi M et al (2019) Seroprevalence of toxoplasmosis among pregnant women in Benin: meta-analysis and meta-regression. Bull Soc Pathol Exot 112(2):79–89CrossRefPubMed Tonouhewa ABN, Amagbegnon R, Atchade SP, Hamidovic A, Mercier A, Dambrun M, Migot-Nabias F, Savi de Tove YS, Sahibi H, Laboudi M et al (2019) Seroprevalence of toxoplasmosis among pregnant women in Benin: meta-analysis and meta-regression. Bull Soc Pathol Exot 112(2):79–89CrossRefPubMed
go back to reference Tété-Bénissan A, Dégbé M, Maman H, Banla AK, Balogou A, Aklikokou K, Gbeassor M (2018) Seroprevalence and risk factors of toxoplasmosis in Togo. Eur Sci J ESJ 14(33):56 Tété-Bénissan A, Dégbé M, Maman H, Banla AK, Balogou A, Aklikokou K, Gbeassor M (2018) Seroprevalence and risk factors of toxoplasmosis in Togo. Eur Sci J ESJ 14(33):56
go back to reference Zhang L, Wang X, Liu M, Feng G, Zeng Y, Wang R, Xie Z (2022) The epidemiology and disease burden of congenital torch infections among hospitalized children in China: a national cross-sectional study. PLoS Negl Trop Dis 16(10):e0010861CrossRefPubMedPubMedCentral Zhang L, Wang X, Liu M, Feng G, Zeng Y, Wang R, Xie Z (2022) The epidemiology and disease burden of congenital torch infections among hospitalized children in China: a national cross-sectional study. PLoS Negl Trop Dis 16(10):e0010861CrossRefPubMedPubMedCentral
Metadata
Title
Toxoplasma gondii seroprevalence and associated factors among pregnant women attending their first antennal care visit in rural Burkina Faso
Authors
Marc Christian Tahita
Bérenger Kaboré
Hamidou Ilboudo
Nadege Zoma
Helkana Melika Sougue
Adama Kazienga
Esther Nadia Ouedraogo
Bienvenu Nana
Elodie D. G. Sanon
Regina Sinner
Halidou Tinto
Judith M. Hübschen
Publication date
04-01-2025
Publisher
Springer India
Keyword
Toxoplasmosis
Published in
Journal of Parasitic Diseases
Print ISSN: 0971-7196
Electronic ISSN: 0975-0703
DOI
https://doi.org/10.1007/s12639-024-01765-0

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more